Resolution of Chronic Subdural Hematoma after Treatment with Tumor Necrosis Factor Alpha Inhibitor
- 1
Abstract
Background and Importance: Chronic subdural hematomas (cSDH) are a common problem for which solutions remain imperfect. Surgery is effective, but not without risk. Recent data have suggested a role for inflammation in the genesis of cSDH and several reports have documented some benefit to steroid treatment. In this report, a possible role for tumor necrosis factor alpha blockade in the resolution of a multiply recurrent cSDH is described. Clinical Presentation: An 86-year-old man with rheumatoid arthritis treated with infliximab presented with a large, symptomatic, multiloculated cSDH. Infliximab was withheld and craniotomy for evacuation was uncomplicated, but recurrent symptoms were noted and a recurrence was operated upon again several weeks later. Follow up CT showed a second recurrence. The patient requested to go back on his infliximab due to painful arthralgias. After a single dose of 10 mg/kg, follow up CT showed that the cSDH resolved and did not recur. Conclusion: Anti-TNF-alpha treatment with infliximab may have played a role in the resolution of this patient’s cSDH. Further investigation of this possible effect seems warranted.
- B. C. Lega, S. F. Danish, N. R. Malhotra, S. S. Sonnad and S. C. Stein, “Choosing the Best Operation for Chronic Subdural Hematoma: A Decision Analysis,” Journal of Neurosurgery, Vol. 113, No. 3, 2010, pp. 615- 621. doi:10.3171/2009.9.JNS08825
- M. Suzuki, S. Endo, K Inada, et al., “Inflammatory Cytokines Locally Elevated in Chronic Subdural Haematoma,” Acta Neurochirurgica (Wien), Vol. 140, No. 1, 1998, pp. 51-55. doi:10.1007/s007010050057
- “Physicians’ Desk Reference,” Thomson Reuters, Montvale, NJ, 2009.
- J. F. Feng, J. Y. Jiang, Y. H. Bao, Y. M. Liang and Y. H. Pan, “Traumatic Subdural Effusion Evolves into Chronic Subdural Hematoma: Two Stages of the Same Inflammatory Reaction?” Medical Hypotheses, Vol. 70, No. 6, 2008, pp. 1147-1149. doi:10.1016/j.mehy.2007.11.014
- T. Shono, T. Inamura, T. Morioka, et al., “Vascular Endothelial Growth Factor in Chronic Subdural Haematomas,” Journal of Clinical Neuroscience, Vol. 8, No. 5, 2001, pp. 411-415. doi:10.1054/jocn.2000.0951
- N. Nanko, M. Tanikawa, M. Mase, et al., “Involvement of Hypoxia-Inducible Factor-1alpha and Vascular Endothelial Growth Factor in the Mechanism of Development of Chronic Subdural Hematoma,” Neurologia Medico- Chirurgica (Tokyo), Vol. 49, No. 9, 2009, pp. 379-385. doi:10.2176/nmc.49.379
- H. J. Hong, Y. J. Kim, H. J. Yi, Y. Ko, S. J. Oh and J. M. Kim, “Role of Angiogenic Growth Factors and Inflammatory Cytokine on Recurrence of Chronic Subdural Hematoma,” Surgical Neurology, Vol. 71, No. 2, 2009, pp. 161-166.
- H. Katano, K. Kamiya, M. Mase, M. Tanikawa and K. Yamada, “Tissue Plasminogen Activator in Chronic Subdural Hematomas as a Predictor of Recurrence,” Journal of Neurosurgery, Vol. 104, No. 1, 2006, pp. 79-84. doi:10.3171/jns.2006.104.1.79
- M. Funai, K. Osuka, N. Usuda, et al., “Activation of P13 kinase/Akt Signaling in Chronic Subdural Hematoma Outer Membranes,” Journal of Neurotrauma, Vol. 28, No. 6, 2011, pp. 1127-1131. doi:10.1089/neu.2010.1498
- M. Tokmak, A. C. Iplikcioglu, S. Bek, C. A. Gokduman and M. Erdal, “The Role of Exudation in Chronic Subdural Hematomas,” Journal of Neurosurgery, Vol. 107, No. 2, 2007, pp. 290-295. doi:10.3171/JNS-07/08/0290
- O. Decaux, B. Cador, T. Dufour, et al., “Traitement des Hematomes Sous-Duraux Chroniques par les Corticoides: A Propos de Deux Observations,” La Revue de Médecine Interne, Vol. 23, No. 9, 2002, pp. 788-791. doi:10.1016/S0248-8663(02)00676-8